The Foundational Concept: The neuromuscular relationship is not one-way command muscles continuously signal health status back to motor neurons. When denervation occurs, dying muscles may send distress signals that accelerate neuronal death.

The Mechanism:

Initial Denervation: Subtle terminal dysfunction possibly from aging, toxins, or subtle axonal transport defects causes some neuromuscular junctions to disconnect. Muscle fibers become orphaned.

Muscle Response: Denervated muscle fibers undergo atrophy but also activate stress pathways. They upregulate muscle-specific genes normally suppressed by innervation.

Myokine Release: Denervated muscle secretes signaling molecules myostatin, GDF15, FGF21, TGF-β family members into circulation and retrograde space.

Retrograde Transport: These myokines bind receptors on residual motor nerve terminals, are internalized, and travel retrogradely via dynein motors to motor neuron cell bodies in spinal cord.

Death Signaling: Once in soma, these signals activate apoptotic pathways caspase-3, JNK, p38 MAPK. Instead of requesting reinnervation, they instruct neuron to die.

Dying-Back Cascade: More denervation releases more myokines, killing more neurons���feed-forward cycle. Pathology progresses from periphery to spinal cord.

The Evidence:

Muscle-specific GDF15 overexpression causes motor neuron loss

Denervated muscle conditioned medium kills motor neurons in culture

SOD1 mice show muscle molecular changes before denervation

Exercise (myokine-modulating) slows ALS progression

The Timing Question:

Muscle changes precede motor neuron death in ALS models

Dying-back pathology well-documented in human ALS

Distal axon degeneration occurs months before cell body loss

Therapeutic Implications:

Myokine-neutralizing antibodies intercepting death signals

Muscle-targeted therapies preventing denervation stress response

Retrograde transport modulators altering signal delivery

Exercise mimetics promoting healthy myokine profile

This reframes ALS as muscle-initiated dying-back peripheral signals driving central neurodegeneration.